Chen Schor - 25 Mar 2026 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Reporting relationship: President & CEO, Director
Issuer ticker: ACET
Reported as of: 25 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Mar 2026, 16:12:24 UTC
Prior SEC filing: 27 Jan 2026
Next SEC filing: 26 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Nick Harvey, Attorney-in-Fact

Key filing fact

Chen Schor filed Form 4 for Adicet Bio, Inc. (ACET) on 27 Mar 2026.

Key facts

This page summarizes Chen Schor's Form 4 filing for Adicet Bio, Inc. (ACET).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Mar 2026, 16:12.

Change

Previous filing in this sequence was filed on 27 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001340875 Primary reporting owner

Schor Chen

Relationship: President & CEO, Director
Address: C/O ADICET BIO, INC., 131 DARTMOUTH STREET, FLOOR 3, BOSTON
Signature: /s/ Nick Harvey, Attorney-in-Fact
Signature date: 27 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACET transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +468,555
Change %
Price: $0.000000^*
Shares after: 468,555
Date: 25 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 468,555
Exercise price: $6.81
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

(1) 1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.